These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4882472)

  • 61. Vinblastine (NSC-49842) plus vincristine (NSC-67574) given in intensive 3-day courses as therapy for lymphomas, sarcomas, and other neoplasms.
    Stolinsky DC; Bogdon DL; Pugh RP; Braunwald J; Hestorff R; Bateman JR
    Cancer Chemother Rep; 1973; 57(4):481-4. PubMed ID: 4586955
    [No Abstract]   [Full Text] [Related]  

  • 62. A controlled evaluation of 5-fluorouracil utilizing a single injection technique.
    Ahmann DL; Moertel CG; Bisel HF; Hahn RG; Schutt AJ; Dines DE
    Oncology; 1974; 29(2):166-71. PubMed ID: 4836677
    [No Abstract]   [Full Text] [Related]  

  • 63. A comparison of 5-fluorouracil administered by slow infusion and rapid injection.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Res; 1972 Dec; 32(12):2717-9. PubMed ID: 4566290
    [No Abstract]   [Full Text] [Related]  

  • 64. Hexamethylmelamine (NSC-13875) for acute leukemia and solid tumors in children.
    Dyment PG; Fernbach DJ; Sutow WW
    J Clin Pharmacol New Drugs; 1973; 13(2):111-3. PubMed ID: 4568295
    [No Abstract]   [Full Text] [Related]  

  • 65. [Results of 5-fluorouracil (5FU) treatment of malignant neoplasms].
    Singer Z; Kuśnierczykówna J; Iwanicka B
    Pol Tyg Lek; 1974 Jun; 29(24):1033-7. PubMed ID: 4845080
    [No Abstract]   [Full Text] [Related]  

  • 66. Chemotherapy with hydroxyurea (NSC-32065) in renal cell carcinoma.
    Nevinny HB; Hall TC
    J Clin Pharmacol J New Drugs; 1968; 8(6):352-9. PubMed ID: 4883783
    [No Abstract]   [Full Text] [Related]  

  • 67. CURRENT STATUS OF 5-FLUOROURACIL THERAPY IN FAR-ADVANCED NEOPLASTIC DISEASE.
    SCHELL HW
    Geriatrics; 1964 Apr; 19():265-70. PubMed ID: 14141804
    [No Abstract]   [Full Text] [Related]  

  • 68. A clinical trial of oral 5-fluorouracil.
    Khung CL; Hall TC; Piro AJ; Dederick MM
    Clin Pharmacol Ther; 1966; 7(4):527-33. PubMed ID: 5939975
    [No Abstract]   [Full Text] [Related]  

  • 69. Phase 1 studies of porfiromycin (NSC-56410).
    Foley HT; Shnider BI; Gold GL; Matias PI; Colsky J; Miller SP
    Cancer Chemother Rep; 1967 Sep; 51(5):283-93. PubMed ID: 4864580
    [No Abstract]   [Full Text] [Related]  

  • 70. TREATMENT OF ADVANCED CANCER WITH 5-FLUOROURACIL.
    HURLEY JD
    Acta Unio Int Contra Cancrum; 1964; 20():363-5. PubMed ID: 14151930
    [No Abstract]   [Full Text] [Related]  

  • 71. An alkaline phenylbutazone preparation.
    Practitioner; 1969 Sep; 203(215):357-60. PubMed ID: 4308703
    [No Abstract]   [Full Text] [Related]  

  • 72. Two new cases of hyperpyrimidinuria associated with excessive 5-fluorouracil toxicity.
    Mans DR; Scaletzky A; Becker D; de Oliveria JR; Pinheiro CM; Bittar C; Ferreira Filho A; Machado VL; Ritt JL; Jung FA
    Ann Oncol; 1994 Oct; 5(8):772-3. PubMed ID: 7826915
    [No Abstract]   [Full Text] [Related]  

  • 73. A synthetic combination in infective gastroenteritis.
    Practitioner; 1969 Jun; 202(212):849-52. PubMed ID: 4240332
    [No Abstract]   [Full Text] [Related]  

  • 74. Methotrexate and the platelet count.
    Ogston D; Dawson AA; Philip JF
    Br J Cancer; 1968 Jun; 22(2):244-9. PubMed ID: 5660130
    [No Abstract]   [Full Text] [Related]  

  • 75. Allopurinol modulation of high-dose fluorouracil toxicity.
    Fox RM; Woods RL; Tattersall HN; Brodie GW
    Cancer Treat Rev; 1979 Jun; 6 Suppl():143-7. PubMed ID: 498168
    [No Abstract]   [Full Text] [Related]  

  • 76. [Clinical evaluation of procarbazine and fluorouracil in advanced lung cancer].
    Bonadonna G; Monfardini S; Oldini C; Guzzon A; Di Pietro S
    Tumori; 1969; 55(5):277-89. PubMed ID: 4909863
    [No Abstract]   [Full Text] [Related]  

  • 77. COMPARISON OF HIGH-DOSAGE AND LOW-DOSAGE-MAINTENANCE THERAPY WITH 5-FLUOROURACIL IN SOLID TUMORS.
    CUDMORE JT; GROESBECK HP
    Cancer; 1964 Feb; 17():230-2. PubMed ID: 14123683
    [No Abstract]   [Full Text] [Related]  

  • 78. Soft-laser therapy for iatrogenic mucositis in cancer patients receiving high-dose fluorouracil: a preliminary report.
    Pourreau-Schneider N; Soudry M; Franquin JC; Zattara H; Martin PM; Ciais G; Namer M; Schneider M; Chauvel P; Demard F
    J Natl Cancer Inst; 1992 Mar; 84(5):358-9. PubMed ID: 1738189
    [No Abstract]   [Full Text] [Related]  

  • 79. [Toxicity and cumulative properties of actinomycins C1, C2 and C3, contained in preparations in various combinations].
    Lupinosov IuV; Denisova SI; Syrkin AB; Gogoleva IA
    Antibiotiki; 1971 May; 16(5):443-6. PubMed ID: 4108776
    [No Abstract]   [Full Text] [Related]  

  • 80. Is toxicity really necessary? II. Source and analysis of data.
    Bross ID; Rimm AA; Slack NH; Ausman RK; Jones R
    Cancer; 1966 Dec; 19(12):1785-95. PubMed ID: 5927938
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.